ArticleThe oncologist2020

Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.

Andge Valiakhmetova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.